The digitalization of biosamples offers an opportunity to permanently retain the information contained in biosamples and maximize data reutilization. However, the digitalized biomedical big data require large-scale information infrastructure to sustain relevant services. With the advancement of biomedical technologies, applications involving gene sequencing and artificial intelligence have exceeded a level that individual researchers or laboratories can afford in terms of data volume, computational capacity, and hardware requirements. The demands for personal information protection, information security, right of information self-determination, and the convenience and functional completeness of data analysis have also made biomedical data application and processing more reliant on advanced information technologies. A biomedical platform that meets the expectations of all stakeholders should thus be established through advanced information technologies to extract the maximum potential from biomedical data.